We Need A Permanent TRIPS Waiver Mechanism
Two years into the pandemic, the trade rules that pose barriers to scaling up production of the vaccines, medicines, tests and other health products we dearly need have not been addressed, highlighting the need for an automatic mechanism to suspend problematic rules when a pandemic, other public health emergencies of international concern, or other exceptional circumstances arise, rather than leaving it to the murky politics of the World Trade Organization.
On 15 March, the European Commission (EC) finally admitted that intellectual property rules pose a threat to vaccine access globally. The counterproposal that was leaked to the press is attributed to the quad of USA, the EC, India and South Africa, but only reflects positions from USA and the EC.